CClinicalTrials.gg
RecruitingNCT05922605Updated Oct 30, 2023

Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

A Phase 4 interventional study of S-ketamine & Ropivacaine and Ropivacaine in Postoperative Analgesia, S-ketamine and Pediatrics, sponsored by Tao Zhang. Recruiting at 1 site in China. Open to male participants aged 3 Months to 18 Years. Per ClinicalTrials.gov, last updated 2023-10-30.

Sponsored by Tao Zhang · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 3 months later.
Phase
Phase 4
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
3 Months to 18 Years
Sex
Male
01

Study summary

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious.

Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.

Read the detailed description

Forty-four children scheduled for hypospadias randomize into 2 groups. Group E (n=22) (0.2% ropivacaine 0.7 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 0.7ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 6-item FLACC score at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more15μg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.

02

Conditions studied

  • Postoperative Analgesia
  • S-ketamine
  • Pediatrics
  • Caudal Block
  • Hypospadias

Browse trials for

03

In context

Hypospadias

131 studies on the registry are indexed under Hypospadias; 34 are open to participants now.

This study's planned enrollment of 44 is below the median of 68 across 102 interventional studies indexed under Hypospadias.

Browse Hypospadias studies →

Lead sponsor

Tao Zhang is the lead sponsor of 16 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 18 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing \<28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited.

Exclusion criteria

Exclusion Criteria:

  • Patients who have congenital abnormalities of lower spine and meninges.
  • Patients with hypersensitivity to any local anesthetics
  • Children with coagulation disorders
  • Presence of Infections at puncture sites
  • Preexisting neurological disease
  • Refusal to consent by parent/guardian
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Group E

    the children are given a mixture of 0.2%ropivacaine 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg for caudal analgesia.

    Drug: S-ketamine & Ropivacaine

  • Active comparator
    Group C

    The children are given 0.2%ropivacaine 0.7 ml/kg and saline of equal volume caudally.

    Drug: Ropivacaine

Interventions

  • DrugS-ketamine & Ropivacaine

    The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.

  • DrugRopivacaine

    The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml/kg plain and equial volume saline caudally for postoperative analgesia.

06

What researchers measure

Primary outcomes

  1. duration of caudal analgesia

    Duration of analgesia is defined as the time from caudal injection to the first need for systemic analgesia.

    Time frame: 48 hours after the caudal injection

Secondary outcomes

  1. morphine consumption

    The Face, Legs, Activity, Cry, and Consolability (FLACC) scale at 1 hour (h), 3h,6h,12h,24h,48h or the time when children complain of pain after surgery. A score of more than 3 points is taken as an indication of inadequate analgesia and morphine 15ug/kg was administered .

    Time frame: 48 hours after caudal block

  2. FLACC score

    The Face, Legs, Activity, Cry, and Consolability (FLACC) scale

    Time frame: 48 hours after the caudal block

  3. complication

    the incidence of residual motor block, urinary retention, paraesthesia; the incidence of respiratory depression ,vomiting ,nystagmus ,pruritus,odd behavior;.the sedation scores etc.

    Time frame: 48 hours after the caudal block

07

Study locations

1 of 1 sites recruiting
  • First Affiliated Hospital, Sun Yat-sen University
    Guangzhou, Guangdong 510000, China
    Recruiting
08

References and documents

Publications

  • Gunes Y, Secen M, Ozcengiz D, Gunduz M, Balcioglu O, Isik G. Comparison of caudal ropivacaine, ropivacaine plus ketamine and ropivacaine plus tramadol administration for postoperative analgesia in children. Paediatr Anaesth. 2004 Jul;14(7):557-63. doi: 10.1111/j.1460-9592.2004.01220.x. PubMed 15200652 ↗
  • De Negri P, Ivani G, Visconti C, De Vivo P. How to prolong postoperative analgesia after caudal anaesthesia with ropivacaine in children: S-ketamine versus clonidine. Paediatr Anaesth. 2001 Nov;11(6):679-83. doi: 10.1046/j.1460-9592.2001.00742.x. PubMed 11696143 ↗
  • Weber F, Wulf H. Caudal bupivacaine and s(+)-ketamine for postoperative analgesia in children. Paediatr Anaesth. 2003 Mar;13(3):244-8. doi: 10.1046/j.1460-9592.2003.01018.x. PubMed 12641687 ↗
  • Martindale SJ, Dix P, Stoddart PA. Double-blind randomized controlled trial of caudal versus intravenous S(+)-ketamine for supplementation of caudal analgesia in children. Br J Anaesth. 2004 Mar;92(3):344-7. doi: 10.1093/bja/aeh076. Epub 2004 Jan 22. PubMed 14742331 ↗
  • Koinig H, Marhofer P, Krenn CG, Klimscha W, Wildling E, Erlacher W, Nikolic A, Turnheim K, Semsroth M. Analgesic effects of caudal and intramuscular S(+)-ketamine in children. Anesthesiology. 2000 Oct;93(4):976-80. doi: 10.1097/00000542-200010000-00017. PubMed 11020749 ↗
  • Brenner L, Marhofer P, Kettner SC, Willschke H, Machata AM, Al-Zoraigi U, Lundblad M, Lonnqvist PA. Ultrasound assessment of cranial spread during caudal blockade in children: the effect of different volumes of local anaesthetics. Br J Anaesth. 2011 Aug;107(2):229-35. doi: 10.1093/bja/aer128. Epub 2011 Jun 3. PubMed 21642642 ↗
  • Narasimhan P, Kashyap L, Mohan VK, Arora MK, Shende D, Srinivas M, Kashyap S, Nath S, Khanna P. Comparison of caudal epidural block with paravertebral block for renal surgeries in pediatric patients: A prospective randomised, blinded clinical trial. J Clin Anesth. 2019 Feb;52:105-110. doi: 10.1016/j.jclinane.2018.09.007. Epub 2018 Sep 19. PubMed 30243061 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05922605
Lead sponsor
Tao Zhang
Responsible party
Tao Zhang (Associate Professor, First Affiliated Hospital, Sun Yat-Sen University) — Sponsor-investigator
First posted
Jun 28, 2023
Start date
Jun 20, 2023
Primary completion
Apr 30, 2025 (estimated)
Completion
May 1, 2025 (estimated)
Last update
Oct 30, 2023

Study contacts

tao Zhang, MD
Contact
zhtao98@aliyun.com
8613580482938
weiyi Xu, B.M
Contact
xuweiyi75@foxmail.com
8619875691896
Tao Zhang, M.D.
study chair · First Affiliated Hospital, Sun Yat-Sen University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion